Bellevue Funds (Lux) - Bellevue Healthcare Strategy I2 Fonds
213,24
EUR
-0,41
EUR
-0,19
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Galderma Group AG Registered Shares | CH1335392721 | 3,72% |
| Thermo Fisher Scientific Inc | US8835561023 | 3,64% |
| AbbVie Inc | US00287Y1091 | 3,63% |
| Sandoz Group AG Registered Shares | CH1243598427 | 3,38% |
| UCB SA | BE0003739530 | 3,19% |
| Eli Lilly and Co | US5324571083 | 3,17% |
| Abbott Laboratories | US0028241000 | 3,11% |
| Boston Scientific Corp | US1011371077 | 3,06% |
| HCA Healthcare Inc | US40412C1018 | 2,99% |
| AstraZeneca PLC | GB0009895292 | 2,98% |
| Sonstige | 67,12% |